当前位置:
X-MOL 学术
›
Ann. Hematol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Correction to: Update on management and progress of novel therapeutics for R/R AML: an Iberian expert panel consensus.
Annals of Hematology ( IF 3.5 ) Pub Date : 2020-01-30 , DOI: 10.1007/s00277-020-03933-7 Pau Montesinos 1, 2 , Juan Bergua 3 , Joana Infante 4 , Jordi Esteve 5 , José Eduardo Guimaraes 6 , Jordi Sierra 7 , Miguel Ángel Sanz 1
Annals of Hematology ( IF 3.5 ) Pub Date : 2020-01-30 , DOI: 10.1007/s00277-020-03933-7 Pau Montesinos 1, 2 , Juan Bergua 3 , Joana Infante 4 , Jordi Esteve 5 , José Eduardo Guimaraes 6 , Jordi Sierra 7 , Miguel Ángel Sanz 1
Affiliation
After publication of this paper, the authors determined that an additional information in the funding section was missing.
中文翻译:
更正为:有关R / R AML的新型疗法的管理和进展的最新动态:伊比利亚专家小组的共识。
在发表本文之后,作者确定缺少资金部分的其他信息。
更新日期:2020-03-06
中文翻译:
更正为:有关R / R AML的新型疗法的管理和进展的最新动态:伊比利亚专家小组的共识。
在发表本文之后,作者确定缺少资金部分的其他信息。